These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 12858189

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
    Irving J, Wang Z, Powell S, O'Sullivan C, Mok M, Murphy B, Cardoza L, Lebkowski JS, Majumdar AS.
    Cancer Gene Ther; 2004 Mar; 11(3):174-85. PubMed ID: 14726958
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL, Ryan P, Gorziglia M, Clarke L, Hawkins LK, Hay C, Huang Y, Kaloss M, Marinov A, Phipps S, Pinkstaff A, Shirley P, Skripchenko Y, Stewart D, Forry-Schaudies S, Hallenbeck PL.
    Cancer Res; 2003 Apr 01; 63(7):1490-9. PubMed ID: 12670895
    [Abstract] [Full Text] [Related]

  • 5. Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice.
    Su C, Peng L, Sham J, Wang X, Zhang Q, Chua D, Liu C, Cui Z, Xue H, Wu H, Yang Q, Zhang B, Liu X, Wu M, Qian Q.
    Mol Ther; 2006 May 01; 13(5):918-27. PubMed ID: 16497559
    [Abstract] [Full Text] [Related]

  • 6. A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent.
    Zou W, Luo C, Zhang Z, Liu J, Gu J, Pei Z, Qian C, Liu X.
    Oncogene; 2004 Jan 15; 23(2):457-64. PubMed ID: 14724574
    [Abstract] [Full Text] [Related]

  • 7. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q, Chen G, Peng L, Wang X, Yang Y, Liu C, Shi W, Su C, Wu H, Liu X, Wu M, Qian Q.
    Clin Cancer Res; 2006 Nov 01; 12(21):6523-31. PubMed ID: 17085667
    [Abstract] [Full Text] [Related]

  • 8. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y, Yu DC, Chen Y, Amin P, Zhang H, Nguyen N, Henderson DR.
    Cancer Res; 2001 Sep 01; 61(17):6428-36. PubMed ID: 11522637
    [Abstract] [Full Text] [Related]

  • 9. [hTERT promoter regulated replication-selective adenovirus CNHK300 in treatment of hepatocellular carcinoma].
    Li YM, Song ST, Jiang ZF, Zhang Q, Su CQ, Xu JM, Qian YZ, Qian QJ.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 23; 85(7):468-72. PubMed ID: 15854553
    [Abstract] [Full Text] [Related]

  • 10. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB, Wu CT, Wang H, Zhang QW, Wang L, Wang RL, Lu ZZ, Wang LS.
    Cancer Gene Ther; 2008 Mar 23; 15(3):173-82. PubMed ID: 18157145
    [Abstract] [Full Text] [Related]

  • 11. Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus.
    Ohashi M, Kanai F, Tateishi K, Taniguchi H, Marignani PA, Yoshida Y, Shiratori Y, Hamada H, Omata M.
    Biochem Biophys Res Commun; 2001 Mar 30; 282(2):529-35. PubMed ID: 11401492
    [Abstract] [Full Text] [Related]

  • 12. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
    Kuppuswamy M, Spencer JF, Doronin K, Tollefson AE, Wold WS, Toth K.
    Gene Ther; 2005 Nov 30; 12(22):1608-17. PubMed ID: 16034456
    [Abstract] [Full Text] [Related]

  • 13. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B, Liu X, Fan J, Qi R, Bo L, Gu J, Qian Q, Qian C, Liu X.
    J Gene Med; 2006 Oct 30; 8(10):1232-42. PubMed ID: 16900558
    [Abstract] [Full Text] [Related]

  • 14. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X, Lu Q, Zhao Y, Ren Z, Ren XW, Qiu QH, Tong Y, Liang M, Hu F, Chen HZ.
    Int J Mol Med; 2005 Dec 30; 16(6):1179-84. PubMed ID: 16273304
    [Abstract] [Full Text] [Related]

  • 15. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H, Wei F, Li H, Ji X, Li S, Chen X.
    Int J Mol Med; 2013 Feb 30; 31(2):377-85. PubMed ID: 23229955
    [Abstract] [Full Text] [Related]

  • 16. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS, Hughes DE, Lichtsteiner SP, Wang Z, Lebkowski JS, Vasserot AP.
    Gene Ther; 2001 Apr 30; 8(7):568-78. PubMed ID: 11319624
    [Abstract] [Full Text] [Related]

  • 17. Dual promoter-controlled oncolytic adenovirus CG5757 has strong tumor selectivity and significant antitumor efficacy in preclinical models.
    Li Y, Idamakanti N, Arroyo T, Thorne S, Reid T, Nichols S, VanRoey M, Colbern G, Nguyen N, Tam O, Working P, Yu DC.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8845-55. PubMed ID: 16361574
    [Abstract] [Full Text] [Related]

  • 18. Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses.
    Bilsland AE, Merron A, Vassaux G, Keith WN.
    Cancer Res; 2007 Feb 01; 67(3):1299-307. PubMed ID: 17283167
    [Abstract] [Full Text] [Related]

  • 19. A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.
    Cafferata EG, Macció DR, Lopez MV, Viale DL, Carbone C, Mazzolini G, Podhajcer OL.
    Clin Cancer Res; 2009 May 01; 15(9):3037-49. PubMed ID: 19336523
    [Abstract] [Full Text] [Related]

  • 20. Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication.
    Kamizono J, Nagano S, Murofushi Y, Komiya S, Fujiwara H, Matsuishi T, Kosai K.
    Cancer Res; 2005 Jun 15; 65(12):5284-91. PubMed ID: 15958575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.